Lymph node biopsy

A lymph node biopsy is a medical procedure where a doctor removes lymph tissue to diagnose or rule out diseases such as lymphoma and metastatic cancer. Most U.S.

Health insurance plans, including Medicare and Blue Cross Blue Shield, cover medically necessary lymph node biopsies if pre-authorization requirements are met. Insurance claims for lymph node biopsy commonly require CPT codes 38500 (superficial), 38525 (deep), or 38510 (cervical) documented on the bill.

Average out-of-pocket costs for an insured patient in the U.S. Range from $100–$1,200, depending on plan details like deductible and coinsurance amounts.

Insurance denials for this procedure most often cite lack of medical necessity documentation or non-covered diagnosis codes such as Z01.818 (“Encounter for other preprocedural examination”). Prior authorization requirements frequently apply with insurers such as UnitedHealthcare and Aetna before scheduling a surgical biopsy at hospitals or ambulatory centers.

Claims for complications from a lymph node biopsy, including infection or lymphedema, typically fall under the initial procedural authorization but may generate separate bills for related care and follow-up visits coded by ICD-10-CM T81.4XXA (infection following a procedure). Short-stay inpatient admissions after a lymph node biopsy, which are rare but occur in less than 2% of cases according to National Inpatient Sample data, trigger different benefit structures under many group insurance policies such as Cigna PPOs.

Preoperative tests required by some insurers before approval–such as imaging (CPT 71260) or blood work (CPT 85027)–are generally covered when bundled with the biopsy claim under proper medical justification. Appeals data from AHIP show that roughly 21% of denied lymph node biopsy claims succeed on first-level review if additional clinical records are submitted within insurer time frames, as revealed by YourInsurance.info.

Coordination of benefits impacts payment order if you have both private insurance and Medicare; primary payers process coverage first based on national coordination rules outlined by CMS. Out-of-network facilities can increase total billing for a lymph node biopsy by more than 300%, according to FAIR Health cost benchmarks, compared to preferred network hospital rates recognized by major carriers like Humana and Anthem.